AntineoplasticsHypersensitivity reactions: 17 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1705卷 / 1期

关键词：

D O I：

10.1007/s40278-018-47052-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：35 / 35

相关论文

共 50 条

[31] PaclitaxelHypersensitivity reaction: 17 case reports
Reactions Weekly, 2019, 1734 (1) : 391 - 391
[32] BevacizumabVarious toxicities: 17 case reports
Reactions Weekly, 2019, 1762 (1) : 83 - 83
[33] AntineoplasticsVarious toxicities: 17 case reports
Reactions Weekly, 2021, 1851 (1) : 40 - 40
[34] InfliximabVarious toxicities: 17 case reports
Reactions Weekly, 2017, 1657 (1) : 239 - 239
[35] VeraliprideExtrapyramidal disorders: 17 case reports
Reactions Weekly, 2005, 1076 (1) : 15 - 15
[36] HydroxychloroquineRetinal toxicity: 17 case reports
Reactions Weekly, 2017, 1680 (1) : 161 - 161
[37] Antirheumatics/antihypertensivesPemphigus: 17 case reports
Reactions Weekly, 2015, 1550 (1) : 20 - 20
[38] AntineoplasticsVarious toxicities: 17 case reports
Reactions Weekly, 2024, 2035 (1) : 71 - 71
[39] Multiple drugsNeurotoxicity: 17 case reports
Reactions Weekly, 2023, 1977 (1) : 207 - 207
[40] AntineoplasticsLack of efficacy: 17 case reports
Reactions Weekly, 2023, 1957 (1) : 48 - 48

← 1 2 3 4 5 →